Health visitors in south Wales set to strike after NHS employer ignores job evaluation appeal
Clinical update
New drug is 'biggest advance' seen for some time in treating certain lung cancers
NICE recommends use of pembrolizumab with pemetrexed and platinum chemotherapy
NICE offers alternative therapy for those diagnosed with lymphoma
National Institute for Health and Care Excellence proposes drug for high-risk neuroblastoma
New guidance by The National Institute for Health and Care Excellence sets out recommendations for NHS treatment be available on the NHS for thyroid cancer patients. &
Summary and nursing implications of the latest updates to clinical practice.
A collaboration between Cancer Drugs Fund and National Institute for Health and Care Excellence has produced a new drug therapy available to some patient
The National Institute for Health and Care Excellence recommends nivolumab is made available for head and neck cancer that has progressed following chemothera
The National Institute for Health and Care Excellence has helped people with advanced kidney cancer to benefit from a new treatment on the NHS.
Life expectancy rates for patients who have myeloma, which affects areas of the body where bone marrow is active, are improving.
Ensuring the safest care for patients undergoing infusion therapy through updated guidance
Your essential guide to signs, symptoms, treatment and the latest guidelines on Non-Hodgkin's lymphoma
